Akcie - Fundamenty - Všechna data pro vaši analýzu

Nástroje

Akciový screener

Kalendář zisků

Super investoři

Ostatní

Návod

IČ: 19940963

5. května 521, 501 01 Turnov

Zásady GDPR

Podmínky služby

Všechna práva vyhrazena @ 2024, Fundamenty.cz

Proudly created by draftspot.net

Oscar Health, Inc.

OSCR

Valuace

100

Růst

Zdraví

Cena

$ 15.02

--0.87 (-4.99%)

Souhrn

Výkazy

Ukazatele

Profil

Držitelé

Návštěvnost webu

Konkurence

Zprávy společnosti

Kapitalizace

3.8B

Obrat

12B

Zisk

Aktiva

Dluh

ROE

ROA

-9

Cena 1R

11-24

⌀ Cena

16.28

Dividenda

0.0(0.0%)

Čtvrtletní 10-Q

Celoroční 10-K

Nadcházející oznámení zisků

10-02-2026

Poslední dividenda

Profil

Oscar Health, Inc. poskytuje produkty a služby zdravotního pojištění ve Spojených státech. Společnost nabízí plány Individual & Family, Small Group a Medicare Advantage a také +Oscar, platformu řízenou technologií, která má pomoci poskytovatelům a platícím klientům zapojit se do spolupráce s členy a pacienty. Poskytuje také zajišťovací produkty. Společnost byla dříve známá jako Mulberry Health Inc. a v lednu 2021 změnila své jméno na Oscar Health, Inc. Společnost Oscar Health, Inc. byla založena v roce 2012 a sídlí v New Yorku.

Sektor

Healthcare

Odvětví

Medical - Healthcare Plans

Počet zaměstnanců

2400

Založení

2021-03-03

Adresa

75 Varick Street

CEO

Mark Thomas Bertolini

Web

www.hioscar.com

Podobné společnosti

ACLX

Arcellx, Inc.

$ 87.47

+ $ 0.92

NAMS

NewAmsterdam Pharma Company N.V.

$ 39.09

+ $ 2.33

AKRO

Akero Therapeutics, Inc.

$ 54.12

+ $ 0.08

ALHC

Alignment Healthcare, Inc.

$ 16.40

+ $ 0.07

OPCH

Option Care Health, Inc.

$ 27.65

- $ 0.01

KYMR

Kymera Therapeutics, Inc.

$ 59.70

+ $ 1.04

IMVT

Immunovant, Inc.

$ 23.05

- $ 0.30

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Rozvaha

Peněžní toky

V miliardách (USD)

Revenue	TTM	2025	2024	2023	2022	2021	2020	2019
Total Revenues	11.70	11.70	9.18	5.86	4.13	1.92	0.59	0.55
Cost of Revenues	10.02	10.02	0.00	0.00	0.00	0.00	0.00	0.00
Gross Profit	1.68	1.68	9.18	5.86	4.13	1.92	0.59	0.55

Revenue	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Total Revenues	2.81	2.99	2.86	3.05	2.39	2.42	2.22	2.14	1.43	1.44
Cost of Revenues	2.62	2.59	2.55	2.26	0.00	0.00	0.00	0.00	0.00	0.00
Gross Profit	0.19	0.40	0.31	0.79	2.39	2.42	2.22	2.14	1.43	1.44

Operating Income	TTM	2025	2024	2023	2022	2021	2020	2019
R&D Expenses	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Selling General & Admin Expenses	0.00	0.00	0.00	0.34	0.31	0.27	0.17	0.11
Depreciation & Amortization	0.03	0.03	0.03	0.03	0.02	0.01	0.01	0.01
Total Operating Expenses	2.08	2.08	9.14	6.10	4.55	-2.50	-1.00	-0.81
Operating Income	-0.40	-0.40	0.03	-0.24	-0.58	-0.58	-0.41	-0.26

Operating Income	TTM	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
R&D Expenses	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Selling General & Admin Expenses	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.09	0.08
Depreciation & Amortization	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Total Operating Expenses	0.52	0.53	0.54	0.49	2.55	2.48	2.16	1.96	1.58	1.50
Operating Income	-0.33	-0.13	-0.23	0.30	-0.15	-0.05	0.06	0.18	-0.15	-0.06

Net Income	TTM	2025	2024	2023	2022	2021	2020	2019
Interest Income	0.00	0.00	0.00	0.00	0.03	0.01	0.01	0.01
Interest Expense	0.02	0.02	0.02	0.02	0.02	0.00	0.00	0.00
Other Expense	-0.04	-0.04	0.00	-0.03	-0.03	0.01	0.00	0.00
IBT	-0.44	-0.44	0.03	-0.27	-0.61	-0.57	-0.41	-0.26
Income Tax Expense	0.01	0.01	0.01	0.00	0.00	0.00	0.00	0.00
Net Income	-0.44	-0.44	0.03	-0.27	-0.61	-0.57	-0.41	-0.26

Net Income	TTM	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Interest Income	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01
Interest Expense	0.00	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Other Expense	-0.02	-0.01	0.00	-0.01	0.00	0.00	0.00	0.00	-0.01	-0.01
IBT	-0.35	-0.14	-0.23	0.29	-0.15	-0.05	0.06	0.18	-0.15	-0.06
Income Tax Expense	0.00	0.00	-0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.00
Net Income	-0.35	-0.14	-0.23	0.28	-0.15	-0.05	0.06	0.18	-0.15	-0.07

Per Share Data	TTM	2025	2024	2023	2022	2021	2020	2019
EPS	$0.00	$0.00	$0.00	$-1.22	$-2.87	$-3.19	$-13.90	$-8.93
EPS Diluted	$0.00	$0.00	$0.00	$-1.22	$-2.87	$-3.19	$-13.90	$-1.29
Shares Outstanding	0.28	0.26	0.24	0.22	0.21	0.18	0.03	0.03
Diluted Shares Outstanding	0.28	0.26	0.27	0.22	0.21	0.18	0.03	0.20

Per Share Data	TTM	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
EPS	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$-0.66	$-0.29
EPS Diluted	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$-0.66	$-0.29
Shares Outstanding	0.28	0.26	0.25	0.25	0.24	0.24	0.24	0.23	0.23	0.22
Diluted Shares Outstanding	0.28	0.26	0.27	0.31	0.27	0.24	0.30	0.29	0.23	0.22

Current Assets	TTM	2024	2023	2022	2021	2020	2019
Cash And Equivalents	2.27	1.53	1.87	1.56	1.10	0.83	0.34
Short Term Investments	0.36	0.62	0.69	1.40	0.59	0.37	0.33
Total Cash & ST Investments	2.63	2.15	2.56	2.96	1.69	1.19	0.67
Accounts Receivable	0.71	0.32	0.20	1.16	0.18	0.10	0.06
Inventory	-2.67	0.00	0.00	-1.16	-0.61	0.00	0.00
Other Current Assets	3.12	0.38	0.30	1.17	0.61	0.00	0.00
Total Current Assets	3.12	2.85	3.06	4.12	1.87	1.29	0.73

Current Assets	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Cash And Equivalents	2.15	2.60	2.24	1.53	1.21	2.27	2.23	1.87	1.40	2.32
Short Term Investments	0.89	0.94	0.75	0.62	0.50	0.36	0.62	0.69	1.04	1.26
Total Cash & ST Investments	3.04	3.54	2.99	2.15	1.71	2.63	2.85	2.56	2.44	3.58
Accounts Receivable	0.45	0.75	0.76	0.32	0.30	0.71	0.65	0.49	0.21	0.19
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-3.05	-0.33	-0.41
Other Current Assets	0.28	0.03	0.02	0.38	0.36	-3.34	-3.49	0.00	0.34	0.42
Total Current Assets	3.76	4.31	3.77	2.85	2.37	0.00	0.00	2.82	2.99	4.19

Long-Term Assets	TTM	2024	2023	2022	2021	2020	2019
Net Property, Plant & Equipment	0.06	0.07	0.06	0.06	0.05	0.04	0.03
Goodwill	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Intangible Assets	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Investments	0.36	1.82	0.37	1.40	0.59	0.37	0.33
Other Long-Term Assets	1.22	0.11	0.11	-1.05	-0.63	-0.40	-0.37
Total Long-Term Assets	1.65	2.00	0.54	0.41	0.63	0.40	0.37
Total Assets	4.76	4.84	3.60	4.53	3.32	2.27	1.35

Long-Term Assets	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Net Property, Plant & Equipment	0.08	0.08	0.07	0.07	0.07	0.06	0.06	0.06	0.06	0.06
Goodwill	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Intangible Assets	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Investments	1.75	1.85	1.87	1.82	1.93	0.36	0.62	0.03	1.04	1.26
Other Long-Term Assets	0.15	0.15	0.12	0.11	0.11	-0.43	-0.68	0.45	-0.75	-0.95
Total Long-Term Assets	1.98	2.07	2.07	2.00	2.11	0.00	0.00	0.54	0.36	0.37
Total Assets	5.75	6.38	5.84	4.84	4.48	5.01	4.42	3.36	3.35	4.56

Current Liabilities	TTM	2024	2023	2022	2021	2020	2019
Accounts Payable	0.41	1.40	0.33	0.73	0.44	0.48	0.49
Short-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Liabilities	2.85	1.77	2.09	2.54	-0.44	-0.48	-0.49
Current Liabilities	3.26	3.17	2.43	3.26	0.44	0.48	0.49

Current Liabilities	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Accounts Payable	0.00	1.57	1.49	1.40	1.41	1.31	1.31	0.33	0.98	0.92
Short-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Liabilities	3.98	3.30	2.66	2.07	1.55	-1.31	-1.31	-0.33	-0.98	2.32
Current Liabilities	3.98	4.87	4.15	3.46	2.95	0.00	0.00	2.19	2.06	3.24

Long-Term Liabilities	TTM	2024	2023	2022	2021	2020	2019
Long-Term Debt	0.30	0.30	0.30	0.30	0.00	0.14	0.00
Capital Leases	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Def. Tax Liability	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Liabilities	3.62	3.82	2.80	3.63	0.44	3.57	0.49

Long-Term Liabilities	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Long-Term Debt	0.69	0.30	0.30	0.30	0.30	0.30	0.30	0.30	0.30	0.30
Capital Leases	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Def. Tax Liability	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Liabilities	4.72	5.22	4.51	3.82	3.32	3.87	3.38	2.55	2.43	3.61

Total Common Equity	TTM	2024	2023	2022	2021	2020	2019
Common Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Retained Earnings	-2.64	-2.85	-2.88	-2.61	-2.00	-1.43	-1.01
Comprehensive Income	0.00	0.00	0.00	-0.01	0.00	0.00	0.00
Total Common Equity	1.14	1.01	0.80	0.89	1.39	-1.30	-0.95

Total Common Equity	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Common Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Retained Earnings	-2.94	-2.80	-2.58	-2.85	-2.70	-2.64	-2.70	-2.88	-2.73	-2.66
Comprehensive Income	0.02	0.01	0.01	0.00	0.03	0.00	0.00	0.00	0.00	-0.01
Total Common Equity	1.02	1.16	1.33	1.01	1.16	1.14	1.03	0.80	0.92	0.95

Other		TTM	2024	2023	2022	2021	2020	2019
Total Debt		0.30	0.30	0.30	0.30	0.00	0.14	0.00
Book Value		1.14	1.02	0.81	0.89	2.88	-1.30	0.85

Other		3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Total Debt		0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Book Value		1.02	1.16	1.33	1.01	1.16	1.14	1.03	0.80	0.92	0.95

Cash Flow From Operating Activities	TTM	2025	2024	2023	2022	2021	2020	2019
Net Income	0.02	-0.44	0.03	-0.27	-0.61	-0.57	-0.41	-0.26
Depreciation & Amortization	0.03	0.03	0.03	0.03	0.02	0.01	0.01	0.01
Stock-Based Compensation	0.11	0.09	0.11	0.16	0.11	0.09	0.04	0.03
Change Working Capital	0.12	1.46	0.84	-0.19	0.86	0.25	0.58	0.06
Change In Accounts Receivable	-0.12	0.10	-0.18	0.64	-0.54	0.08	-0.10	-0.31
Change In Accounts Payable	0.07	0.17	0.13	-0.40	0.28	-0.04	-0.01	0.28
Change In Inventories	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Non-cash Items	0.09	-0.04	-0.03	0.00	0.00	0.04	0.01	-0.01
Cash from Operations	0.28	0.00	0.00	-0.27	0.38	-0.18	0.22	-0.17

Cash Flow From Operating Activities	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Net Income	-0.35	-0.14	-0.23	0.28	-0.15	-0.05	0.06	0.18	-0.15	-0.07
Depreciation & Amortization	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Stock-Based Compensation	0.02	0.02	0.02	0.02	0.03	0.03	0.03	0.03	0.03	0.03
Change Working Capital	0.99	-0.85	0.73	0.59	0.47	-0.84	0.41	0.43	0.39	-1.11
Change In Accounts Receivable	0.10	0.05	0.03	-0.08	-0.04	0.10	-0.06	-0.15	0.01	0.06
Change In Accounts Payable	0.09	-0.04	-0.07	0.18	0.02	0.05	0.04	0.03	0.01	0.00
Change In Inventories	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Non-cash Items	0.01	-0.01	-0.02	-0.02	-0.01	0.36	-0.01	-0.01	0.02	-0.01
Cash from Operations	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.30	-1.15

Cash Flow From Investing Activities	TTM	2025	2024	2023	2022	2021	2020	2019
Capital Expenditure	-0.03	-0.04	-0.03	-0.03	-0.03	-0.03	-0.01	-0.03
Acquisitions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	-1.66	-1.01	-2.13	-0.84	-1.19	-1.81	-1.00	-0.88
Sales of Investment	1.31	0.80	0.77	1.44	0.99	1.05	0.67	1.06
Other Investing Activities	0.00	0.00	0.00	0.00	0.00	0.01	0.00	-0.01
Cash from Investing	-0.38	0.00	0.00	0.58	-0.23	-0.77	-0.34	0.15

Cash Flow From Investing Activities	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Capital Expenditure	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01
Acquisitions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	-0.23	-0.17	-0.27	-0.34	-0.11	-0.66	-0.81	-0.56	-0.22	-0.08
Sales of Investment	0.19	0.33	0.11	0.17	0.09	0.09	0.34	0.26	0.40	0.32
Other Investing Activities	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash from Investing	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.17	0.23

Cash Flow From Financing Activities	TTM	2025	2023	2022	2021	2020
Debt Repaid	0.00	0.00	0.00	0.00	-0.15	0.00
Debt Issued	0.00	0.30	0.00	0.30	0.01	0.14
Issuance of Common Stock	0.05	0.00	0.00	0.00	1.35	0.00
Repurchase of Common Stock	0.00	0.00	0.00	0.00	0.00	0.00
Dividends Paid	0.00	0.00	0.00	0.00	0.00	0.00
Other Financing Activities	0.05	0.00	0.01	0.30	0.04	0.61
Cash from Financing	0.05	0.00	0.01	0.30	1.24	0.61

Cash Flow From Financing Activities	4-2025	3-2025
Debt Repaid	0.00	0.00
Debt Issued	0.69	0.39
Issuance of Common Stock	0.00	0.00
Repurchase of Common Stock	0.00	0.00
Dividends Paid	0.00	0.00
Other Financing Activities	0.00	0.00
Cash from Financing	0.00	0.00

Cash position		TTM	2025	2024	2023	2022	2021	2020	2019
Net Change in Cash		-0.05	1.25	-0.34	0.31	0.45	0.28	0.49	-0.02
Closing Cash Balance		2.27	2.80	1.55	1.89	1.58	1.13	0.84	0.35

Cash position		4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Net Change in Cash		0.63	-0.45	0.36	0.71	0.32	-1.06	0.04	0.36	0.47	-0.92
Closing Cash Balance		2.77	2.15	2.62	2.26	1.55	1.23	2.29	2.25	1.87	1.42

Free Cash Flow		TTM	2025	2024	2023	2022	2021	2020	2019
Free Cash Flow		0.25	1.06	0.95	-0.30	0.35	-0.21	0.21	-0.19
Real Free Cash Flow		0.14	0.97	0.84	-0.46	0.24	-0.29	0.17	-0.22

Free Cash Flow		4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Free Cash Flow		0.66	-0.97	0.50	0.87	0.34	-0.51	0.49	0.63	0.29	-1.16
Real Free Cash Flow		0.64	-0.99	0.48	0.84	0.31	-0.54	0.46	0.60	0.26	-1.18

Nacenění

Finance

Efektivita

Marže

Dividenda

Ostatní

Nacenění

Ukazatel	Aktuální	Historické	Konkurence
P/E	-8.8	29.7	51.6
P/S	0.3	1	0.9
P/B	3.8	2.4	21.2
P/FCF	3.8	-4.2	152.6
Market cap	$3.8	$3.7

P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel	Aktuální	Historické	Srovnání
Debt to Assets	0 %	4.7 %	0 %
Debt to Income	-154.9 %	105.4 %	0 %
Debt to Free cash flow	70.7 %	52.6 %	0 %
Interest expense percentage	-4.4 %	-1.2 %	0 %
Current ratio	0.9	1.2	0